The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mashkova T.A.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko MZ RF

Mal'tsev A.B.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko

Nerovnyĭ A.I.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko MZ RF

Bakulina L.S.

N.N. Burdenko Voronezh State Medical University, Ministry of Health of the Russian Federation, Voronezh, Russia, 394036

The role of a leukotriene receptor antagonist in the restoration of the nasal breathing in the patients presenting with polypous rhinosinusitis

Authors:

Mashkova T.A., Mal'tsev A.B., Nerovnyĭ A.I., Bakulina L.S.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2017;82(5): 32‑35

Read: 6619 times


To cite this article:

Mashkova TA, Mal'tsev AB, Nerovnyĭ AI, Bakulina LS. The role of a leukotriene receptor antagonist in the restoration of the nasal breathing in the patients presenting with polypous rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2017;82(5):32‑35. (In Russ.)
https://doi.org/10.17116/otorino201782532-35

Recommended articles:
Anti­fungal immu­nity in patients with chro­nic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2024;(6):40-45
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10
Syne­rgistic effi­ciency of preformed physical factors and dupi­lumab in the treatment of poly­pous rhinosinusitis. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):16-23

References:

  1. Kim IA, Nosulya EV. Features epidemiology polypoid rhinosinusitis. Rossijskaja rinologija. 2007;2:24. (In Russ.)
  2. Egorov VI, Kozarenko AV, Slesarenko AV. On the treatment of rhinosinusitis polypous. Rossijskaja rinologija. 2013;2:65. (In Russ.)
  3. Pauli C, Fintelmann R, Klemens C, Hilgert E, Jund F, Rasp G, Hagedorn H, Kramer MF. Polyposis nasi-improvement in quality of life by the influence of leukotrien receptor antagonists. Laryngorhinootologie. 2007;86(4):282-286. https://doi.org/10.1055/s-2007-966094
  4. Lopatin AS. Corticosteroid therapy in rhinology. Rossijskaja rinologija. 2001;2:138. (In Russ.)
  5. Ryazantsev SV. Modern views on therapy polypous rhinosinusiti. Pul’monologiya i allergologiya. 2007;4:22-26. (In Russ.)
  6. Akhtar S, Ikram M, Azam I, Dahri T. Factors associated with recurrent nasal polyps: a tertiary care experience. J Pak Med Assoc. 2010;60(2):102-104.
  7. Rasp G. Is there a role for leukotriene antagonists in the prevention of recurrent nasal polyps? Curr Opin Allergy Clin Immunol. 2010;10(3):200-205. https://doi.org/10.1097/ACI.0b013e328339117f
  8. Schaper C, Noga O, Koch B, Ewert R, Felix SB, Glaser S, Kunkel G, Gustavus B. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergol Clin Immunol. 2011;21(1):51-58.
  9. Cingi C, Muluk NB, Ipci K, Sahin E. Antileukotrienes in upper airway inflammatory diseases. Curr Allergy Asthma Rep. 2015;15(11):64. https://doi.org/ 10.1007/s11882-015-0564-7
  10. Voznesenskii NA. Leukotriene receptor antagonists in treatment of asthma and allergic rhinitis. Pul’monologiya i allergologiya. 2008;3:1-3. (In Russ.)
  11. Geppe NA, Farber IM. Place leukotriene receptor antagonist in the treatment of children with asthma and allergic rhinitis. Effektivnaya farmakoterapiya. Pul’monologiya i otorinolaringologiya. 2011;2:29-34. (In Russ.)
  12. Kieff DA, Busaba NY. Efficacy of montelukast in the treatment of nasal polyposis. Ann Otol Rhinol Laryngol. 2005;114(12):941-945. https://doi.org/10.1177/000348940511401209
  13. Ovchinnikov YuM, Ovcharenko SI, Ovchinnikov AYu, Chichkova NV, Gumeniuk VA. Anti-leukotriene therapy of patients with allergic rhinosinusitis and bronchial asthma. Vestnik otorinolaringologii. 2002;(3):31-34. (In Russ.)
  14. Soldatov IB, Khrappo NS, Shcherbakov VA. Variant classification polypoid sinusitis. Rossijskaja rinologija. 1997;2:16. (In Russ.)
  15. Piskunov GZ, Piskunov SZ. Klinicheskaja rinologija. M.: Meditsinskoe informatsionnoe agentstvo; 2006. (In Russ.)
  16. Pollard J.H. A handbook of numerical and statistical thechniques. M.: Finansy i statistika; 1982. (In Russ.)
  17. Goryachkina LA, Drobik OS, Biteeva DV. Leukotriene receptor antagonists in the treatment of bronchial asthma. Vestnik semejnoj mediciny. 2010;5-6:1-4. (In Russ.)
  18. Geppe NA, Revyakina VA. New international guidelines for asthma in children PRACTALL. Prakticheskaya pul’monologiya. 2008;1:60-68. (In Russ.)
  19. Vuralkan E, Saka C, Akin I, Hucumenoglu S, Unal BU, Kuran G, Ocal B. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps. Ther Adv Respir Dis. 2012;6(1):5-10. https://doi.org/10.1177/1753465811427577
  20. Rudmik L, Soler ZM. Medical Therapies for Adult Chronic Sinusitis: A Systematic Review. JAMA. 2015;314(9):926-939. https://doi.org/10.1001/jama.2015.7544

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.